$3335 | Single User
$3680 | Site License
$5520 | Enterprise License

North America Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)
[Lowest Price Guaranteed: $3,335]

Published by Market Data Forecast: 01 Dec 2016 | 49377 | In Stock
Related Topics: Boehringer Ingelheim , Novartis , Protein , Veterinary

Introduction

The North America animal vaccines market is poised to reach 71.69 Million by 2020 from 07.26 Million in 2015, at a CAGR of 4.93% from 2015 to 2020. The major goals of veterinary vaccines are to improve the health companion animals, increase production of livestock in a cost-effective manner, and prevent zoonotic disease transmission from both domestic and wild animals. Veterinary vaccine market has shown significant growth in recent years which can be attributed to increasing husbandry practices and better management of farms. This marks the estimation of further growth in the market due to advancement in biotechnological research.

The North America veterinary vaccines market has undergone considerable progress during the past few years with the growing usage of continuous cell lines as a substrate and embracing of the fermenter technology for antigen production. These vaccines are produced for administration by parenteral or oral routes depending on the vaccine characteristics. But it should be kept in mind that USDA APHIS regulations must be stringently followed for approval and distribution of veterinary biologics across USA which is the major economy in this region.

Growing prevalence of animal diseases, rising incidences of zoonotic diseases in humans; increasing investments by leading players, various government agencies and animal associations; continuous innovations, increasing awareness against the use of antimicrobials is driving the vaccine producers to invest significantly into development of new products. However, rising maintenance costs for the storage of vaccines, increasing adoption of vegetarian diet in major economies owing to increasing risk of obesity and other chronic diseases are key restraints of this market.

The North America veterinary vaccines market has been categorized as livestock and companion vaccines. The livestock vaccines segment has been further segmented into five categories namely, bovine, porcine, ovine, poultry and equine. The companion animal vaccines segment has also been further categorized into feline and canine vaccines. In addition, based on production technologies the market is segmented as live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines. The canine vaccines segment accounted for a slightly larger share (in terms of revenue) than the feline vaccines segment, due to higher average cost allied with canine vaccination. Similarly, the bovine vaccines sub-segment accounted for the largest share (in terms of revenue), followed by porcine. Furthermore, on the basis of geography, the North America market is analysed under various regions namely, USA and Canada.

Some of the key players influencing the market are Bayer HealthCare AG, Bioniche Animal Health Canada, Sanofi Animal Health, Inc., Biogenesis Bago SA, Heska Corporation, Indian Immunologicals Ltd., Boehringer Ingelheim GmbH, Zoetis, Novartis Animal Heath, Inc., Merck & Co. Inc, and Protein Sciences.

Table of Contents
for North America Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

  • Introduction

    1.1 Market Definition

    1.2 Study Deliverables

    1.3 Base Currency, Base Year and Forecast Periods

    1.4 General Study Assumptions

    Research Methodology

    2.1 Introduction

    2.2 Analysis Design

    2.3 Research Phases

    2.3.1 Secondary Research

    2.3.2 Primary Research

    2.3.3 Econometric Modelling

    2.3.4 Expert Validation

    2.4 Study Timeline

    Overview

    3.1 Executive Summary

    3.2 Key Inferences

    3.3 New Developments

    Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

    4.1 Market Drivers

    4.2 Market Restraints

    4.3 Key Challenges

    4.4 Current Opportunities in the Market

    Market Segmentation

    5.1 By Type

    5.1.1 Livestock vaccines

    5.1.1.1 Bovine

    5.1.1.2 Porcine

    5.1.1.3 Ovine

    5.1.1.4 Poultry

    5.1.1.5 Equine

    5.1.2 Companion vaccines

    5.1.2.1 Canine

    5.1.2.2 Feline

    5.2 Technology

    5.2.1 Live attenuated vaccines

    5.2.2 Inactivated vaccines

    5.2.3 Recombinant vaccines

    5.2.4 Toxoid vaccines

    5.2.5 Subunit vaccines

    5.2.6 DNA vaccines

    5.2.7 Conjugate vaccines

    Geographical Analysis

    6.1 Introduction

    6.2 United States

    6.3 Canada

    Strategic Analysis

    7.1 PESTLE analysis

    7.1.1 Political

    7.1.2 Economic

    7.1.3 Social

    7.1.4 Technological

    7.1.5 Legal

    7.1.6 Environmental

    7.2 Porter’s Five analysis

    7.2.1 Bargaining Power of Suppliers

    7.2.2 Bargaining Power of Consumers

    7.2.3 Threat of New Entrants

    7.2.4 Threat of Substitute Products and Services

    7.2.5 Competitive Rivalry within the Industry

    Market Leaders' Analysis

    8.1 Bayer Healthcare AG

    8.1.1 Overview

    8.1.2 Product Analysis

    8.1.3 Strategic Evaluation and Operations

    8.1.4 Financial analysis

    8.1.5 Legal issues

    8.1.6 Recent Developments

    8.1.7 SWOT analysis

    8.1.8 Analyst View

    8.2 Bioniche Animal Health Canada

    8.3 Sanofi Animal Health Inc.

    8.4 Biogenesis Bago SA

    8.5 Heska Corporation

    8.6 Indian Immunologicals Ltd.

    8.7 Boehringer Ingelheim GmbH

    8.8 Novartis Animal Health, Inc.

    8.9 Merck & Co. Inc.

    8.10 Protein Sciences

    Competitive Landscape

    9.1 Market share analysis

    9.2 Merger and Acquisition Analysis

    9.3 Agreements, collaborations and Joint Ventures

    9.4 New Product Launches

    Expert Opinions

    10.1 Market Outlook

    10.2 Investment Opportunities

    Appendix

    List of Tables

    List of Figures

Additional Details

Publisher

Market Data Forecast

Publisher Information

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Reference

49377 | North America Veterinary Vaccines Market

Number of Pages

134

Report Format

PDF

Market Data Forecast Reports

Related Reports

TitleDate PublishedPrice fromMore Details
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC) a subsidiary of North China Pharmaceutical Group ...
11 Jul 2016 by Global Data USD $300 More Info
University of North Carolina - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUniversity of North Carolina (UNC) is an educational service provider that offers academic co...
13 May 2016 by Global Data USD $250 More Info
North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
11 May 2016 by Global Data USD $250 More Info
North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorth China Pharmaceutical Group Corp. (NCPC) is a pharmaceutical company that manufactures a...
10 May 2016 by Global Data USD $250 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
15 Apr 2016 by Global Data USD $300 More Info
University of North Carolina - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryUniversity of North Carolina (UNC) is an educational service provider that offers academic co...
17 Mar 2016 by Global Data USD $250 More Info
North China Pharmaceutical Co., Ltd. (600812) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
15 Mar 2016 by Global Data USD $250 More Info
North China Pharmaceutical Group Corp. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNorth China Pharmaceutical Group Corp. (NCPC) is a pharmaceutical company that manufactures a...
15 Mar 2016 by Global Data USD $250 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
09 Jan 2016 by Global Data USD $300 More Info
North China Pharmaceutical Co., Ltd. (600812) - Financial and Strategic SWOT Analysis Review
SummaryNorth China Pharmaceutical Co., Ltd. (NCPC), a subsidiary of China Pharmaceutical Group is a ...
08 Nov 2015 by Global Data USD $300 More Info

This report is published by Market Data Forecast

Market Data Forecast [MDF] is a firm working in the areas of market research, business intelligence and consulting. We have rich experience in research and consulting for various business domains to cater to the needs of both individual and corporate clients. A few key business areas that we handle with excellence include business process improvement, corporate financing and decision making based on market research, assisting in developing appropriate strategy and providing consultancy based on extensive research. 

Download Free Report Summary PDF

North America Veterinary Vaccines Market by Type (Livestock Vaccines and Companion Vaccines), by Technology (live attenuated vaccines, inactivated vaccines, recombinant vaccines, toxoid vaccines, subunit vaccines, DNA vaccines and conjugate vaccines) and by region - Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021) | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...